Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.
Adult
Ambulatory Care Facilities
Anti-HIV Agents
/ administration & dosage
Choice Behavior
Delivery of Health Care, Integrated
Female
Focus Groups
HIV Infections
/ prevention & control
Humans
Interviews as Topic
Malawi
Male
Patient Preference
Pre-Exposure Prophylaxis
/ methods
Qualitative Research
Risk Reduction Behavior
Sex Workers
/ psychology
Sexual Partners
Young Adult
Africa
Pre-exposure prophylaxis
Sex workers
Women
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
14
11
2019
medline:
27
5
2020
entrez:
14
11
2019
Statut:
ppublish
Résumé
Female sex workers (FSW) in Malawi have among the highest HIV prevalence estimates worldwide. Daily oral pre-exposure prophylaxis (PrEP) is an effective HIV prevention method, yet preferences for PrEP delivery among FSW are lacking. Eight focus group discussions, a literature review, and cognitive interviews were conducted to identify modifiable PrEP delivery attributes and inform discrete-choice experiment (DCE) development for FSW in Lilongwe. Enrolled FSW received an interviewer-assisted DCE. Data were analyzed using mixed logit regression. Dispensing location was most preferred, followed by the provision of additional services. Women preferred receiving PrEP at family planning clinics or non-governmental organization run drop-in centers. Cervical cancer screening was the most preferred additional service, while pregnancy testing and partner risk reduction counseling were less valued. This study was the first study to examine PrEP delivery preferences in Malawi using DCE-a powerful elicitation tool to apply to other key populations at risk for HIV.
Identifiants
pubmed: 31720955
doi: 10.1007/s10461-019-02705-3
pii: 10.1007/s10461-019-02705-3
pmc: PMC7995177
mid: NIHMS1542739
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1294-1303Subventions
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : Center for AIDS Research, University of North Carolina at Chapel Hill
ID : P30 AI50410
Références
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
Health Econ Rev. 2013 May 11;3(1):14
pubmed: 23663390
J Acquir Immune Defic Syndr. 2019 May 1;81(1):24-35
pubmed: 30964804
Int J STD AIDS. 2003 Mar;14(3):185-8
pubmed: 12665441
AIDS Behav. 2012 May;16(4):920-33
pubmed: 21750918
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
Afr J AIDS Res. 2016 Dec;15(4):377-386
pubmed: 27974017
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8
pubmed: 22267018
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):339-47
pubmed: 23187945
PLoS One. 2013;8(1):e54288
pubmed: 23342121
Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25132
pubmed: 30033589
J Sex Transm Dis. 2016;2016:7673014
pubmed: 27493826
Health Policy Plan. 2009 Mar;24(2):151-8
pubmed: 19112071
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
PLoS One. 2014 Feb 21;9(2):e89118
pubmed: 24586534
PLoS One. 2014 Jan 22;9(1):e86200
pubmed: 24465956
Cult Health Sex. 2013;15(4):450-65
pubmed: 23414116
Int J STD AIDS. 2012 Apr;23(4):267-73
pubmed: 22581951
AIDS Care. 2015;27(5):665-8
pubmed: 25495796
Med Decis Making. 2018 Jan;38(1):120-133
pubmed: 28863752
Issues Brief (Alan Guttmacher Inst). 2014;(2):1-8
pubmed: 26159000
Value Health. 2013 Jan-Feb;16(1):3-13
pubmed: 23337210
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):394-403
pubmed: 30633040
Lancet. 2015 Jan 3;385(9962):72-87
pubmed: 25059942
Soc Sci Med. 2017 Jan;172:115-123
pubmed: 27866750
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S248-51
pubmed: 25723991
Sex Transm Dis. 2008 Dec;35(12):1002-8
pubmed: 19051397
AIDS Behav. 2012 Jul;16(5):1308-15
pubmed: 21947835
PLoS One. 2013 Dec 30;8(12):e83193
pubmed: 24386160
PLoS One. 2016 Jan 25;11(1):e0147662
pubmed: 26808043
Dev Health Econ Public Policy. 2014;12:27-48
pubmed: 24864381
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
Reprod Health. 2017 Jan 19;14(1):13
pubmed: 28103896
AIDS. 2013 Aug 24;27(13):2155-60
pubmed: 24384592
J Glob Oncol. 2017 Apr 21;3(5):480-489
pubmed: 29094086
Patient. 2010 Dec 1;3(4):249-56
pubmed: 22273432
BMJ Open. 2016 Sep 26;6(9):e011595
pubmed: 27678533
PLoS One. 2013 Nov 25;8(11):e81041
pubmed: 24282565
PLoS One. 2012;7(3):e32627
pubmed: 22403685